Thursday, January 04, 2018 10:15 PM ET
Insider Selling in Biohaven Pharmaceutical Holding (BHVN) Shares Continues
There was a notable sale of shares of Biohaven Pharmaceutical Holding by an insider today, as revealed in a form 4 document filed with the SEC. One insider — PORTAGE BIOTECH INC., 10% Owner — sold 35,650 shares in the company having a market value of approximately $1,020,071. There have been 3 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 388,950 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 424,600 shares and have averaged 106,150 shares per transaction over this time period.
The number of insider buy/sell trades at Biohaven Pharmaceutical Holding is higher than that of the 190 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 157 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by Biohaven Pharmaceutical Holding insiders is lower than its peers. Within the peer group there were 26,685,061 shares purchased and 11,230,698 shares sold with company insiders acquiring 132,089 shares on average over this time period.
To bring into focus significant insider buying and selling activity, all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers has been eliminated in data sourced to create and write this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.